Breakthrough experimental therapy to treat colon cancer, chronic inflammatory bowel disease

Breakthrough experimental therapy to treat colon cancer, chronic inflammatory bowel disease

UCLA scientists have discovered a groundbreaking experimental therapy that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer. The treatment utilizes a chemical inhibitor able to block an RNA molecule (microRNA-214) involved in the transmission of genetic information.